Skip to content
As a general rule, when you hear about a tiny biotech "partnering" with a Big Pharma giant to market a drug, it's the smaller company that's doing all the work -- and the larger company that's providing the marketing heft (and the money to market the drug). But this news is a bit different. In fact, it's the exact opposite of what you'd ordinarily expect.Nabriva Therapeutics (NBRV), a microcap biotech based in Dublin, Ireland, announced Thursday that it will partner up with American Big Pharma giant Merck (MRK) to market Merck's "SIVEXTRO" antibiotic for treating acute bacterial skin and skin structure infections (ABSSSI) caused by Gram-positive pathogens (bacteria that produce a crystal violet stain result when subjected to the Gram stain test).SIVEXTRO is used to treat such common conditions as abscesses, cellulitis, and wound infections often caused by Staphylococcus aureus and Streptococcus pyogenes.Merck owns the rights to SIVEXTRO, originally approved by the US...
Eldorado Resorts (NASDAQ: ERI) shares are trading lower on Frida after reports emerged New Jersey regulators are mulling Eldorado buyout of Caesars Entertainment Corporation (NASDAQ: CZR).Eldorado Resorts is a gaming and hospitality company. It owns and operates gaming facilities located in Ohio, Louisiana, Nevada, Pennsylvania, and West Virginia. The primary source of revenue is generated by gaming operations, the company utilizes its hotels, restaurants, bars, entertainment, retail shops, racing, and other services to attract customers to their properties.It owns and operates various properties, such as Eldorado Resort Casino Reno; Silver Legacy Resort Casino; Circus Circus Reno and many other properties.Eldorado Resorts shares were trading down 6.13% at $38.27 during the time of publication on Friday. The stock has a 52-week high of $70.74 and a 52-week low of $6.02.See more from Benzinga * Why RumbleON's Stock Is Trading Higher Today * Netflix Falls On Mixed Q2 Earnings, Lower Subscriber Outlook *...
On CNBC's "Mad Money Lightning Round," Jim Cramer said Teladoc Health Inc (NYSE: TDOC) is one of those companies whose valuation got stretched. He wants to see a pullback of 10% off its highs before he pulls the trigger and buy.Cramer would stay long in WEX Inc (NYSE: WEX). He is not concerned about the recent downgrade.The Boeing Company (NYSE: BA) is going to have a 25 points downside risk and a 150 points upside potential when a vaccine occurs, believes Cramer. He wouldn't double down with this name.Instead of buying calls in Coca-Cola Co (NYSE: KO), Cramer would just own the stock because it has got a good dividend yield.Palo Alto Networks Inc (NYSE: PANW), Crowdstrike Holdings Inc (NASDAQ: CRWD), Zscaler Inc (NASDAQ: ZS) and Proofpoint Inc (NASDAQ: PFPT) are better than FireEye Inc (NASDAQ: FEYE), said Cramer.Ingevity Corp (NYSE: NGVT) is just a plain-old industrial and that is exactly...
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […]...
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Equity Income Fund posted a return of 18.29% for the quarter, underperforming its benchmark, the S&P 500 Index which returned 20.55% in the same quarter. You should check out Brown Advisory’s top 5 stock picks for investors […]...
Chris Taylor, CEO of Great Bear Resources, discusses where gold prices may go next with Yahoo Finance’s Alexis Christoforous, Brian Sozzi and Jared Blikre....
Intuitive Surgical soared to a record high a couple of days after breaking out. The maker of robotic surgical systems likely benefiting from coronavirus vaccine hopes. A vaccine would let surgeries go back to normal. The only problem with ISRG – besides being extended now – is that earnings are due Tuesday night....
